|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-2-19
|
|
pubmed:abstractText |
Malignant pleural mesothelioma (MPM) is a highly aggressive tumour with poor prognosis and limited response to therapy. MPM is characterised by complex chromosomal aberrations, including chromosome 10 losses. The tumour suppressor gene phosphatase and tensin homologue deleted from chromosome 10 (PTEN) located on chromosome 10q23 plays an important role in different cancer, but its relevance for MPM is unclear.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1010-7940
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
502-6
|
|
pubmed:meshHeading |
pubmed-meshheading:18248818-Animals,
pubmed-meshheading:18248818-Antibodies, Monoclonal,
pubmed-meshheading:18248818-Gene Expression,
pubmed-meshheading:18248818-Genes, Tumor Suppressor,
pubmed-meshheading:18248818-Humans,
pubmed-meshheading:18248818-Immunohistochemistry,
pubmed-meshheading:18248818-Lung Neoplasms,
pubmed-meshheading:18248818-Mesothelioma,
pubmed-meshheading:18248818-Mice,
pubmed-meshheading:18248818-Microarray Analysis,
pubmed-meshheading:18248818-Neoplasm Proteins,
pubmed-meshheading:18248818-PTEN Phosphohydrolase,
pubmed-meshheading:18248818-Survival Analysis
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
PTEN expression is a strong predictor of survival in mesothelioma patients.
|
|
pubmed:affiliation |
Division of Thoracic Surgery, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland.
|
|
pubmed:publicationType |
Journal Article
|
